Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $100

Benzinga · 01/05 18:45
Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from $82 to $100.